Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)

China flag China · Delayed Price · Currency is CNY
35.25
+0.47 (1.35%)
At close: Apr 29, 2026
112.73%
Market Cap 3.81B
Revenue (ttm) 197.68M
Net Income (ttm) 48.60M
Shares Out 108.22M
EPS (ttm) 0.54
PE Ratio 65.83
Forward PE n/a
Dividend 0.32 (0.92%)
Ex-Dividend Date n/a
Volume 2,428,397
Average Volume 3,604,427
Open 34.66
Previous Close 34.78
Day's Range 34.44 - 35.97
52-Week Range 16.43 - 42.50
Beta 0.37
RSI 59.15
Earnings Date Apr 25, 2026

About SHA:688163

Shanghai Serum Bio-Technology Co., Ltd. engages in the research, development, production, operation, and sales of antitoxin and antiserum products in China. It offers equine anti-tetanus immunoglobulin, anti-venin, and anti-rabies serum products. The company was founded in 1999 and is based in Shanghai, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 324
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688163
Full Company Profile

Financial Performance

In 2025, SHA:688163's revenue was 196.21 million, an increase of 0.66% compared to the previous year's 194.92 million. Earnings were 51.79 million, an increase of 16.93%.

Financial Statements

News

There is no news available yet.